IE
CHE icon

Israel Englander’s Chemed CHE Stock Holding History

Israel Englander’s Portfolio CHE Stock Details CHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-14,300
Closed -$7.58M – 5915
2024
Q4 		$7.58M Buy
+14,300
New +$8.06M ﹤0.01% 2440

Other funds holding CHE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
EIP
Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return

Israel Englander's CHE Position: Q2 2026 in Review

Israel Englander reduced its Chemed (CHE) stake by 52% in Q2 2026, selling an estimated $22.8M and leaving 50,404 shares worth $23.5M. The position accounts for 0.01% of the portfolio, ranked #1484.

Israel Englander first reported a position in CHE in Q4 2014 and has held it in 41 quarters since. The position peaked at $74.6M in Q4 2024. 529 funds tracked by Wall St. Rank hold CHE as of Q2 2026.

  • Israel Englander held 50,404 shares of Chemed worth $23.5M as of Q2 2026.
  • Israel Englander sold 54,211 Chemed shares in Q2 2026, an estimated $22.8M.
  • Chemed made up 0.01% of Israel Englander's portfolio in Q2 2026, its #1484 holding.
  • Israel Englander first reported a position in Chemed in Q4 2014 and has held it in 41 quarters since.
  • Israel Englander's Chemed position peaked at $74.6M in Q4 2024.
  • 529 funds tracked by Wall St. Rank held Chemed as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.